121 related articles for article (PubMed ID: 38824957)
41. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
[TBL] [Abstract][Full Text] [Related]
42. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB;
J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335
[TBL] [Abstract][Full Text] [Related]
44. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
[TBL] [Abstract][Full Text] [Related]
45. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
Burt TD; Agan BK; Marconi VC; He W; Kulkarni H; Mold JE; Cavrois M; Huang Y; Mahley RW; Dolan MJ; McCune JM; Ahuja SK
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8718-23. PubMed ID: 18562290
[TBL] [Abstract][Full Text] [Related]
47. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.
DeCarli C; Reed T; Miller BL; Wolf PA; Swan GE; Carmelli D
Stroke; 1999 Aug; 30(8):1548-53. PubMed ID: 10436099
[TBL] [Abstract][Full Text] [Related]
48. Ideal vitamin D and handgrip strength counteracts the risk effect of APOE genotype on dementia: a population-based longitudinal study.
Feng J; Wang Q; Zhang Y
J Transl Med; 2023 May; 21(1):355. PubMed ID: 37246226
[TBL] [Abstract][Full Text] [Related]
49. Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele.
Sundström A; Nilsson LG; Cruts M; Adolfsson R; Van Broeckhoven C; Nyberg L
Int Psychogeriatr; 2007 Feb; 19(1):159-65. PubMed ID: 16684399
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
[TBL] [Abstract][Full Text] [Related]
51. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
[TBL] [Abstract][Full Text] [Related]
52. Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort.
Jiang F; Mishra SR; Shrestha N; Ozaki A; Virani SS; Bright T; Kuper H; Zhou C; Zhu D
Lancet Public Health; 2023 May; 8(5):e329-e338. PubMed ID: 37062296
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study.
Lehmann DJ; Refsum H; Nurk E; Warden DR; Tell GS; Vollset SE; Engedal K; Nygaard HA; Smith AD
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):902-8. PubMed ID: 16595618
[TBL] [Abstract][Full Text] [Related]
54. APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality.
Satizabal CL; Samieri C; Davis-Plourde KL; Voetsch B; Aparicio HJ; Pase MP; Romero JR; Helmer C; Vasan RS; Kase CS; Debette S; Beiser AS; Seshadri S
Stroke; 2018 Dec; 49(12):2822-2829. PubMed ID: 30571417
[TBL] [Abstract][Full Text] [Related]
55. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
56. Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.
Johnson EL; Krauss GL; Lee AK; Schneider ALC; Dearborn JL; Kucharska-Newton AM; Huang J; Alonso A; Gottesman RF
JAMA Neurol; 2018 Nov; 75(11):1375-1382. PubMed ID: 30039175
[TBL] [Abstract][Full Text] [Related]
57. Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan.
Kulminski AM; Arbeev KG; Culminskaya I; Arbeeva L; Ukraintseva SV; Stallard E; Christensen K; Schupf N; Province MA; Yashin AI
PLoS Genet; 2014 Jan; 10(1):e1004141. PubMed ID: 24497847
[TBL] [Abstract][Full Text] [Related]
58. Exposure to air pollution and risk of incident dementia in the UK Biobank.
Parra KL; Alexander GE; Raichlen DA; Klimentidis YC; Furlong MA
Environ Res; 2022 Jun; 209():112895. PubMed ID: 35149105
[TBL] [Abstract][Full Text] [Related]
59. The APOE epsilon 4 polymorphism does not predict late onset depression: the Three-City Study.
Tully PJ; Péres K; Berr C; Tzourio C
Neurobiol Aging; 2016 Apr; 40():191.e9-191.e10. PubMed ID: 26785975
[TBL] [Abstract][Full Text] [Related]
60. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.
Eriksson UK; Bennet AM; Gatz M; Dickman PW; Pedersen NL
Alzheimer Dis Assoc Disord; 2010; 24(3):213-9. PubMed ID: 20473139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
